Nicholson Nur 4

Accession 0001492422-26-000040

CIK 0001492422other

View on SEC.gov Company Profile

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:12 PM ET

Size

4.5 KB

Accession

0001492422-26-000040

Research Summary

AI-generated summary of this filing

Updated Jan 21, 2026

Apellis (APLS) CTO Nicholson Nur Sells 2,203 Shares

What Happened
Nicholson Nur, Chief Technical Officer of Apellis Pharmaceuticals (APLS), sold 2,203 shares on January 20, 2026 at $19.79 per share, generating proceeds of $43,604. The filing shows this sale was to cover tax withholding on Restricted Stock Units (RSUs) that vested on January 16, 2026 — a routine disposition rather than a standalone investment decision.

Key Details

Transaction date and price: 2026-01-20, 2,203 shares at $19.79 each (total $43,604)
Transaction type: Sale (open market or private sale) executed to satisfy tax withholding obligations
Footnote: Shares sold to cover tax withholding on RSUs released Jan 16, 2026 (Footnote F1)
Shares owned after transaction: Not disclosed in the provided filing excerpt
Filing timeliness: Report filed on Jan 21, 2026 (within normal Form 4 reporting window)

Context
Sales to cover tax withholding for vested RSUs are common and typically reflect routine administrative needs rather than a view on the company's prospects. For retail investors, purchases usually carry more signal value than routine withholding sales; this transaction should be viewed in that context.